← All stocks

STANDARD BIOTOOLS INC.

LAB No buying or selling

CIK 0001162194 #3739 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

10 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Casdin Partners Master Fund, L.P. entity

Director

—

74,906,470

$108.37M

+30.7%

Egholm Michael

President & CEO

—

6,137,704

$8.88M

+305.8%

Casdin Eli

Director

—

3,053,169

$4.42M

+8.8%

Kim Hanjoon Alex

Chief Financial Officer

—

2,534,859

$3.67M

+339.6%

Mackay Sean

SVP & Chief Business Officer

—

1,480,823

$2.14M

+146.8%

Cox Troy

Director

—

475,702

$688.25K

+194.0%

Carey Thomas D.

Director

—

344,456

$498.36K

+698.7%

ELOI FENEL M

Director

—

335,299

$485.11K

+136.8%

Witney Frank

Director

—

309,978

$448.48K

+166.6%

HIBBS KATHY L

Director

—

236,836

$342.65K

+449.1%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 21 Oct 2016